Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University, 74 Zhongshan Rd 2, 510080, Guangzhou, China.
Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
BMC Psychiatry. 2022 Nov 30;22(1):749. doi: 10.1186/s12888-022-04392-2.
Depressive symptoms among adolescents are a serious health concern around the world. Altered DNA methylation in the FK506 binding protein 5 (FKBP5) gene has been reported to regulate stress response, which has been reported to be closely associated with depressive symptoms. However, most of the contributing studies have been conducted among adults and relatively few studies have considered the effect of disparate social influences and sex differences on the DNA methylation of FKBP5 in persons with depressive symptoms. The present study aimed to test the associations of FKBP5 DNA methylation and depressive symptoms among adolescents and explore possible sex differences in the foregoing associations.
This study was conducted using a nested case-control design within a longitudinal cohort study from January 2019 to December 2019. Adolescents aged 12 to 17 years from 69 classes in 10 public high schools located in Guangdong province of China participated in this research. Students with persistent depressive symptoms that reported having depressive symptoms at both baseline and follow-up were treated as the case group, and those without depressive symptoms were randomly selected as the control group. Our study finally included 87 cases and 151 controls. Quantitative methylation analyses of the selected gene were carried out by MassARRAY platform System.
The overall DNA methylation trend of FKBP5 CpG sites in the case group was lower in comparison to the control group. Compared to healthy controls, lower methylation percentage of FKBP5-12 CpG 1 was observed in adolescents with persistent depressive symptoms after adjusting for covariates (case: 0.94 ± 2.00, control: 0.47 ± 0.92; F = 5.41, P = 0.021), although the statistical significance of the difference was lost after false discovery rate correction (q > 0.05). In addition, the hypomethylation of FKBP5-12 CpG 1 was approaching significance after adjustment for social-environmental factors (aOR = 0.77; P = 0.055), which indicated that no independent association was detected between hypomethylation of FKBP5 CpG sites and persistent depressive symptoms. Furthermore, in the present study, we were unable to identify sex differences in the association of FKBP5 gene methylation with depressive symptoms.
The decreased methylation level of FKBP5 was observed in adolescents with persistent depressive symptoms, albeit non-significant after correction for multiple testing. Our results presented here are preliminary and underscore the complex gene-environment interactions relevant to the risk for depressive symptoms.
青少年的抑郁症状是全球范围内一个严重的健康问题。FK506 结合蛋白 5(FKBP5)基因的 DNA 甲基化改变已被报道能调节应激反应,这与抑郁症状密切相关。然而,大多数相关研究都是在成年人中进行的,很少有研究考虑不同的社会影响和性别差异对有抑郁症状的人 FKBP5 基因 DNA 甲基化的影响。本研究旨在检验 FKBP5 基因 DNA 甲基化与青少年抑郁症状之间的关联,并探讨上述关联中可能存在的性别差异。
本研究采用 2019 年 1 月至 12 月在中国广东省 10 所公立高中的 69 个班级中进行的纵向队列研究中的嵌套病例对照设计。来自 12 至 17 岁的青少年参加了这项研究。在基线和随访时均报告有抑郁症状的持续性抑郁症状患者被视为病例组,而没有抑郁症状的患者则被随机选为对照组。我们的研究最终纳入了 87 例病例和 151 例对照。通过 MassARRAY 平台系统对选定基因的定量甲基化分析。
与对照组相比,病例组 FKBP5 基因 CpG 位点的总体 DNA 甲基化趋势较低。在调整协变量后,与健康对照组相比,持续性抑郁症状青少年 FKBP5-12 CpG1 的甲基化百分比较低(病例:0.94±2.00,对照:0.47±0.92;F=5.41,P=0.021),但在经过错误发现率校正(q>0.05)后,差异的统计学意义丧失。此外,在调整社会环境因素后,FKBP5-12 CpG1 的低甲基化接近显著(aOR=0.77;P=0.055),这表明 FKBP5 CpG 位点的低甲基化与持续性抑郁症状之间没有独立的关联。此外,在本研究中,我们无法确定 FKBP5 基因甲基化与抑郁症状之间的关联存在性别差异。
在持续性抑郁症状的青少年中观察到 FKBP5 基因的甲基化水平降低,尽管在经过多次测试校正后无统计学意义。我们在这里呈现的结果是初步的,强调了与抑郁症状风险相关的复杂基因-环境相互作用。